ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 288

$679K Total Retail Price of All Prescriptions

Rank: 30 out of 288

339 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 339 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 339 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,070 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 410 305 1 3
AMLODIPINE BESYLATE 405 321 2 6
FUROSEMIDE 322 279 3 5
PRAVASTATIN SODIUM 305 232 4 21
LEVOTHYROXINE SODIUM 303 253 5 2
HYDROCODONE-ACETAMINOPHEN 281 189 S3 6 7
POTASSIUM CHLORIDE 263 205 7 11
WARFARIN SODIUM 239 199 8 9
METOPROLOL TARTRATE 234 197 9 8
RANITIDINE HCL 230 178 10 33
LISINOPRIL 225 174 11 4
SIMVASTATIN 210 178 12 1
GABAPENTIN 164 81 13 17
CITALOPRAM HBR 160 151 14 18
ZOLPIDEM TARTRATE 160 106 14 22
CRESTOR 159 114 16 26
TRAMADOL HCL 133 102 17 19
METFORMIN HCL 128 79 18 12
NAMENDA 128 128 18 39
ATORVASTATIN CALCIUM 126 105 20 14
DONEPEZIL HCL 121 113 21 29
ALENDRONATE SODIUM 121 107 21 20
LOSARTAN POTASSIUM 119 101 23 16
SPIRIVA 119 88 23 48
ZETIA 111 67 25 58
DOXAZOSIN MESYLATE 111 94 25 78
SPIRONOLACTONE 107 85 27 36
NEXIUM 97 37 28 43
ADVAIR DISKUS 96 56 29 50
ALLOPURINOL 87 58 30 23
SINGULAIR 86 34 31 86
POLYETHYLENE GLYCOL 3350 84 48 32 38
FAMOTIDINE 82 59 33 68
CARVEDILOL 79 66 34 27
FLUTICASONE PROPIONATE 78 47 35 41
PREDNISONE 75 63 36 30
HYDRALAZINE HCL 72 71 37 95
CYMBALTA 71 29 38 67
SERTRALINE HCL 69 59 39 25
BUSPIRONE HCL 69 57 39 135
NOVOLOG FLEXPEN 69 52 39 168
HYDROCHLOROTHIAZIDE 68 62 42 13
FENTANYL 68 47 S2 42 57
NOVOLOG 64 32 44 91
LANTUS SOLOSTAR 64 47 44 81
PROAIR HFA 62 42 46 45
DIOVAN 62 53 46 53
GLIMEPIRIDE 57 44 48 32
ESCITALOPRAM OXALATE 57 47 48 87
TRICOR 56 31 50 115
CLONIDINE HCL 56 40 50 70
METOPROLOL SUCCINATE 55 51 52 15
INSULIN SYRINGE 55 35 52 79
LANTUS 53 31 54 31
SYNTHROID 53 38 54 63
JANUVIA 52 33 56 88
ATENOLOL 52 43 56 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.